These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Purging in BCR-ABL-positive acute lymphoblastic leukemia using immunomagnetic beads: comparison of residual leukemia and purging efficiency in bone marrow vs peripheral blood stem cells by semiquantitative polymerase chain reaction. Atta J; Fauth F; Keyser M; Petershofen E; Weber C; Lippok G; Hoelzer D; Martin H Bone Marrow Transplant; 2000 Jan; 25(1):97-104. PubMed ID: 10654022 [TBL] [Abstract][Full Text] [Related]
3. Autologous and allogeneic transplantation with peripheral blood CD34+ cells: a pediatric experience. Watanabe T; Kawano Y; Watanabe A; Takaue Y Haematologica; 1999 Feb; 84(2):167-76. PubMed ID: 10091416 [TBL] [Abstract][Full Text] [Related]
4. The efficiency of tumor cell purging using immunomagnetic CD34+ cell separation systems. Roots-Weiss A; Papadimitriou C; Serve H; Hoppe B; Koenigsmann M; Reufi B; Oberberg D; Thiel E; Berdel WE Bone Marrow Transplant; 1997 Jun; 19(12):1239-46. PubMed ID: 9208119 [TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of simultaneous immunomagnetic CD34+ cell selection and breast cancer cell purging in peripheral blood progenitor cell samples used for hematopoietic rescue after high-dose therapy. Mohr M; Hilgenfeld E; Fietz T; Hoppe B; Koenigsmann M; Hoffmann M; Knauf WU; Cassens U; Sibrowski W; Kienast J; Thiel E; Berdel WE Clin Cancer Res; 1999 May; 5(5):1035-40. PubMed ID: 10353736 [TBL] [Abstract][Full Text] [Related]
6. Efficient and nontoxic adenoviral purging method for autologous transplantation in breast cancer patients. Lillo R; Ramírez M; Alvarez A; Santos S; García-Castro J; Fernández de Velasco J; Avilés MJ; Gómez-Pineda A; Díez JL; Balas A; Vicario JL; Bueren JA; García-Sánchez F Cancer Res; 2002 Sep; 62(17):5013-8. PubMed ID: 12208755 [TBL] [Abstract][Full Text] [Related]
7. Autologous transplantation of chemotherapy-purged PBSC collections from high-risk leukemia patients: a pilot study. Lemoli RM; Visani G; Leopardi G; Motta MR; Rizzi S; Testoni N; Curti A; Tura S Bone Marrow Transplant; 1999 Feb; 23(3):235-41. PubMed ID: 10084254 [TBL] [Abstract][Full Text] [Related]
8. Similar survival following HLA-identical sibling transplantation for standard indication in children with haematologic malignancies: a single center comparison of mobilized peripheral blood stem cell with bone marrow transplantation. Meisel R; Enczmann J; Balzer S; Bernbeck B; Kramm C; Schönberger S; Sinha K; Tröger A; Wernet P; Göbel U; Laws HJ; Dilloo D Klin Padiatr; 2005; 217(3):135-41. PubMed ID: 15858704 [TBL] [Abstract][Full Text] [Related]
9. [Ex vivo and in vivo purging for PBSCT]. Moriyama Y Rinsho Byori; 1999 May; Suppl 110():79-84. PubMed ID: 10475035 [TBL] [Abstract][Full Text] [Related]
10. Purging of peripheral blood stem cell transplants in AML: a predictive model based on minimal residual disease burden. Feller N; Jansen-van der Weide MC; van der Pol MA; Westra GA; Ossenkoppele GJ; Schuurhuis GJ Exp Hematol; 2005 Jan; 33(1):120-30. PubMed ID: 15661405 [TBL] [Abstract][Full Text] [Related]
11. Ex-vivo purging of hematopoietic progenitor cells. de Lima M; Shpall EJ Curr Hematol Rep; 2004 Jul; 3(4):257-64. PubMed ID: 15217555 [TBL] [Abstract][Full Text] [Related]
12. [Manipulation of hematopoietic stem cell grafts and their use in clinical practice]. Sumerauer D; Matĕjcková S; Hrubá A; Eckschlager T Cas Lek Cesk; 2002 Jul; 141(13):411-6. PubMed ID: 12238028 [TBL] [Abstract][Full Text] [Related]
13. CD34(+) hematopoietic progenitor cell selection of bone marrow grafts for autologous transplantation in pediatric patients. Kasow KA; Sims-Poston L; Eldridge P; Hale GA Biol Blood Marrow Transplant; 2007 May; 13(5):608-14. PubMed ID: 17448921 [TBL] [Abstract][Full Text] [Related]
14. [Collection of hematopoietic progenitor cells from healthy donors]. Bojanić I; Cepulić BG; Mazić S Acta Med Croatica; 2009 Jun; 63(3):237-44. PubMed ID: 19827352 [TBL] [Abstract][Full Text] [Related]
15. [Methods of mobilizing hematopoietic cells, their collection using cell separation, purging--processing of pathologic cells and enrichment with CD 34+ cells--negative and positive selection]. Walter Z; Szostek M; Mensah P; Lorenz F; Weglarska D; Skotnicki AB Przegl Lek; 1999; 56 Suppl 1():22-7. PubMed ID: 10494178 [TBL] [Abstract][Full Text] [Related]
16. Randomised comparison of two B-cell purging protocols for patients with B-cell non-Hodgkin lymphoma: in vivo purging with rituximab versus ex vivo purging with CliniMACS CD34 cell enrichment device. van Heeckeren WJ; Vollweiler J; Fu P; Cooper BW; Meyerson H; Lazarus HM; Simic A; Laughlin MJ; Gerson SL; Koç ON Br J Haematol; 2006 Jan; 132(1):42-55. PubMed ID: 16371019 [TBL] [Abstract][Full Text] [Related]
17. In vivo purging and relapse prevention following ASCT. Gisselbrecht C Bone Marrow Transplant; 2002 Feb; 29 Suppl 1():S5-9. PubMed ID: 11840154 [TBL] [Abstract][Full Text] [Related]
18. Transplantation of haematopoietic stem cells derived from cord blood, bone marrow or peripheral blood: a single centre matched-pair analysis in a heterogeneous risk population. Schönberger S; Niehues T; Meisel R; Bernbeck B; Laws HJ; Kögler G; Enzmann J; Wernet P; Göbel U; Dilloo D Klin Padiatr; 2004; 216(6):356-63. PubMed ID: 15565551 [TBL] [Abstract][Full Text] [Related]